Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018)

PURPOSE: To evaluate the in vitro activity of ceftolozane/tazobactam and comparator agents tested against Pseudomonas aeruginosa and Enterobacterales isolates from hospitalised patients in Asia. Ceftolozane/tazobactam is an antipseudomonal cephalosporin combined with a well-established β-lactamase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, Michael, Shortridge, Dee, Chen, Wei-Ting, Sader, Helio, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700433/
https://www.ncbi.nlm.nih.gov/pubmed/36444213
http://dx.doi.org/10.2147/IDR.S387097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700433/
https://www.ncbi.nlm.nih.gov/pubmed/36444213
http://dx.doi.org/10.2147/IDR.S387097

Ejemplares similares